Holding(s) in Company
Lanstead Capital Investors LP has notified Immupharma plc of a change in its major holding, reducing its voting rights from 17.99% to 14.67% as of September 9, 2026. This reduction represents 91,523,156 ordinary shares, with no voting rights held through financial instruments. The total number of voting rights in Immupharma plc is 623,911,379. Lanstead Capital Investors LP is not controlled by any other entity and does not control any other undertakings holding an interest in Immupharma.
Select text to share a quote on X · sign in to keep highlights & notes in your IMM notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Lanstead Capital Investors LP |
City and country of registered office (if applicable)
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 9/9/2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 10/9/2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 14.67% | 0.00% | 14.67% | 623,911,379 |
| Position of previous notification (if applicable) | 17.99% | 0.00% | 17.99% | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) | Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) | |
| Ordinary Shares ISIN: GB0033711010 | 91,523,156 | 0 | 14.67% | 0.00% |
| SUBTOTAL 8. A | 91,523,156 | 14.67% | ||
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
N/A
SUBTOTAL 8. B 1
N/A
SUBTOTAL 8.B.2
N/A
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
| Place of completion | LON |
| Date of completion | 10/9/2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.